Young Health Products and its co-founder, Deanna Naylor, have been formally warned by the U.S. Food and Drug Administration, or FDA, for medical claims the agency say go well beyond the types of claims dietary supplements are allowed to carry.
Young Health’s promises run the gamut. Autism, Alzheimer’s, heart disease, diabetes, arthritis, cancer, IBS, skin conditions, pain . . . if you can name it, Young Health probably has a product for it.
Young Health’s Lugol’s Solution 2%
The company’s Lugol’s Solution 2% product is an iodine solution that got the FDA’s dander up for its claims that it can treat thyroid issues, balance hormones and reduce diabetics’ need for insulin:
Young Health’s Probimune
The company’s Probimune product is a little more multi-purpose. It promises relief from allergy, gut inflammation and high blood pressure:
The company was also called out for claims made in an online brochure. This one was made about ingredients in the marketing spiel for the Flax Seed & Omega 3-6-9 Fish Oil product:
“. . . can help nourish the body when attacked by conditions like cardiovascular disease, cancer, diabetes, neurological illnesses like Alzheimer’s & autism, arthritis, and asthma.”
As is typical with cases like this, Young Health was given 15 working days to answer the FDA’s allegations and present a plan to correct the violations.
The FDA warning letter to Deanna Naylor and Young Health Products was dated January 24, 2018; as you can see from the screengrabs taken this afternoon, Young Health has yet to remove the allegedly violating health claims.
Categories: FDA Warning Letters